興 柏 集 團

以專精特新企業建設為抓手 實施高質量發展戰略

興柏集團作為獲得石家莊市2021年度主導產業專項資金獎補的企業之一，《石家莊日報》對我集團分公司河北興柏農業科技有限公司負責人劉進峰進行了專訪。在采訪中，劉總對獲得這次獎補，十分激動，同時對市委、市政府對我們企業發展的關注及大力支持表示衷心的感謝。

以下是此次報道全部內容:

Xingbai Group

Implementing high-quality development strategy with the construction of new, distinctive, specialized and sophisticated enterprise

Xingbai Group, as one of the companies that have won the 2021 leading industry special fund award in Shijiazhuang City, the Shijiazhuang Daily conducted an exclusive interview with Liu Jinfeng, the person in charge of Hebei Xingbai Agricultural Technology Co., Ltd., a branch of our group.

In the interview, Mr. Liu was quite excited about the award, and expressed his heartfelt thanks to the Municipal Government for their attention and support to our development.

Hebei Xingbai Agricultural Technology Co., Ltd. is located in Zhao County Economic Development Zone, its leading industry is biopharmaceuticals, with microbial fermentation technology as a breakthrough point, the layout of agricultural development in urgent need of green and efficient new formulations, new varieties, is the national key support for high-tech field of industry. Our representative product abamectin fermentation scale ranks among the forefront of the national production capacity, the industrial scale and technology level plays a leading role in the industry. We has three major R&D platforms (provincial enterprise technology center, academician workstation and key laboratory of abamectin biotechnology in Hebei Province), and two major product quality control centers (strain selection and breeding center, central laboratory).

In recent years, Our group has closely focused on biological fermentation technology, implemented diversified business strategies, strictly controlled product quality, focused on the supply of upstream and downstream products, and closely connected the industrial chain. It has obtained 2 leading scientific and technological achievements in China, 1 provincial and municipal scientific and technological progress award, 1 provincial scientific and technological invention award, and the scientific and technological project "Abamectin High-efficiency Microbial Synthesis and Biological Manufacturing" won the second prize of National Science and Technology Progress Award, applied for more than 30 national invention patents, owned 11 authorized patents for core inventions, registered more than 100 brand trademarks of international and domestic products, established a consistent intellectual property system and built a high-value patent pool.

Xingbai group plans to complete its listing on the main board of the Hong Kong Stock Exchange by the end of June 2023 and to be listed on the domestic domestic A-share by the end of June 2024.

Editor of this article: Kou Na